Lifemd Preferred Series Preferred Stock Probability of Future Preferred Stock Price Finishing Under 21.81

LFMDP Preferred Stock  USD 22.90  0.14  0.62%   
LifeMD Preferred's future price is the expected price of LifeMD Preferred instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of LifeMD Preferred Series performance during a given time horizon utilizing its historical volatility. Check out LifeMD Preferred Backtesting, LifeMD Preferred Valuation, LifeMD Preferred Correlation, LifeMD Preferred Hype Analysis, LifeMD Preferred Volatility, LifeMD Preferred History as well as LifeMD Preferred Performance.
  
Please specify LifeMD Preferred's target price for which you would like LifeMD Preferred odds to be computed.

LifeMD Preferred Target Price Odds to finish below 21.81

The tendency of LifeMD Preferred Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 21.81  or more in 90 days
 22.90 90 days 21.81 
about 20.18
Based on a normal probability distribution, the odds of LifeMD Preferred to drop to $ 21.81  or more in 90 days from now is about 20.18 (This LifeMD Preferred Series probability density function shows the probability of LifeMD Preferred Stock to fall within a particular range of prices over 90 days) . Probability of LifeMD Preferred Series price to stay between $ 21.81  and its current price of $22.9 at the end of the 90-day period is about 73.97 .
Assuming the 90 days horizon LifeMD Preferred Series has a beta of -0.3. This indicates as returns on the benchmark increase, returns on holding LifeMD Preferred are expected to decrease at a much lower rate. During a bear market, however, LifeMD Preferred Series is likely to outperform the market. Additionally LifeMD Preferred Series has an alpha of 0.1667, implying that it can generate a 0.17 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   LifeMD Preferred Price Density   
       Price  

Predictive Modules for LifeMD Preferred

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LifeMD Preferred Series. Regardless of method or technology, however, to accurately forecast the preferred stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the preferred stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LifeMD Preferred's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
21.5522.9024.25
Details
Intrinsic
Valuation
LowRealHigh
17.6018.9525.19
Details
Naive
Forecast
LowNextHigh
21.5122.8624.20
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
21.6422.4223.20
Details

LifeMD Preferred Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. LifeMD Preferred is not an exception. The market had few large corrections towards the LifeMD Preferred's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold LifeMD Preferred Series, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of LifeMD Preferred within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.17
β
Beta against Dow Jones-0.3
σ
Overall volatility
0.45
Ir
Information ratio 0.01

LifeMD Preferred Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LifeMD Preferred for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LifeMD Preferred Series can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
LifeMD Preferred has high likelihood to experience some financial distress in the next 2 years
LifeMD Preferred Series has accumulated 1.41 M in total debt with debt to equity ratio (D/E) of 0.46, which is about average as compared to similar companies. LifeMD Preferred Series has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist LifeMD Preferred until it has trouble settling it off, either with new capital or with free cash flow. So, LifeMD Preferred's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like LifeMD Preferred Series sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for LifeMD to invest in growth at high rates of return. When we think about LifeMD Preferred's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 92.88 M. Net Loss for the year was (60.9 M) with profit before overhead, payroll, taxes, and interest of 74.88 M.
LifeMD Preferred Series has accumulated about 5.84 M in cash with (33.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.

LifeMD Preferred Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of LifeMD Preferred Stock often depends not only on the future outlook of the current and potential LifeMD Preferred's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LifeMD Preferred's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding30.6 M
Cash And Short Term Investments41.3 M

LifeMD Preferred Technical Analysis

LifeMD Preferred's future price can be derived by breaking down and analyzing its technical indicators over time. LifeMD Preferred Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of LifeMD Preferred Series. In general, you should focus on analyzing LifeMD Preferred Stock price patterns and their correlations with different microeconomic environments and drivers.

LifeMD Preferred Predictive Forecast Models

LifeMD Preferred's time-series forecasting models is one of many LifeMD Preferred's preferred stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary LifeMD Preferred's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the preferred stock market movement and maximize returns from investment trading.

Things to note about LifeMD Preferred Series

Checking the ongoing alerts about LifeMD Preferred for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for LifeMD Preferred Series help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
LifeMD Preferred has high likelihood to experience some financial distress in the next 2 years
LifeMD Preferred Series has accumulated 1.41 M in total debt with debt to equity ratio (D/E) of 0.46, which is about average as compared to similar companies. LifeMD Preferred Series has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist LifeMD Preferred until it has trouble settling it off, either with new capital or with free cash flow. So, LifeMD Preferred's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like LifeMD Preferred Series sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for LifeMD to invest in growth at high rates of return. When we think about LifeMD Preferred's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 92.88 M. Net Loss for the year was (60.9 M) with profit before overhead, payroll, taxes, and interest of 74.88 M.
LifeMD Preferred Series has accumulated about 5.84 M in cash with (33.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.

Additional Tools for LifeMD Preferred Stock Analysis

When running LifeMD Preferred's price analysis, check to measure LifeMD Preferred's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD Preferred is operating at the current time. Most of LifeMD Preferred's value examination focuses on studying past and present price action to predict the probability of LifeMD Preferred's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD Preferred's price. Additionally, you may evaluate how the addition of LifeMD Preferred to your portfolios can decrease your overall portfolio volatility.